Our analysis reveals that, regardless of the tumour stage, TGF-β exerts a potent suppressor effect on iCCA tumour cells that is dependent on a functional SMAD2/3/4 complex and that inhibition of TGF-β receptors boosts iCCA progression by promoting tumour cell growth. This evidence concerns the gene SMAD2 and neoplasm.